搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Mycobacterium ulcerans 30S ribosomal protein S19 (rpsS) CSB-YP370665MOP
CSB-EP370665MOP
CSB-BP370665MOP
CSB-MP370665MOP
CSB-EP370665MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans 50S ribosomal protein L16 (rplP) CSB-YP370666MOP
CSB-EP370666MOP
CSB-BP370666MOP
CSB-MP370666MOP
CSB-EP370666MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans 50S ribosomal protein L24 (rplX) CSB-YP370667MOP
CSB-EP370667MOP
CSB-BP370667MOP
CSB-MP370667MOP
CSB-EP370667MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans 50S ribosomal protein L18 (rplR) CSB-YP370668MOP
CSB-EP370668MOP
CSB-BP370668MOP
CSB-MP370668MOP
CSB-EP370668MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans 50S ribosomal protein L15 (rplO) CSB-YP370669MOP
CSB-EP370669MOP
CSB-BP370669MOP
CSB-MP370669MOP
CSB-EP370669MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans Putative S-adenosyl-L-methionine-dependent methyltransferase MUL_0818 (MUL_0818) CSB-YP370670MOP
CSB-EP370670MOP
CSB-BP370670MOP
CSB-MP370670MOP
CSB-EP370670MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans Translation initiation factor IF-1 (infA) CSB-YP370671MOP
CSB-EP370671MOP
CSB-BP370671MOP
CSB-MP370671MOP
CSB-EP370671MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans 30S ribosomal protein S11 (rpsK) CSB-YP370672MOP
CSB-EP370672MOP
CSB-BP370672MOP
CSB-MP370672MOP
CSB-EP370672MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans 30S ribosomal protein S4 (rpsD) CSB-YP370673MOP
CSB-EP370673MOP
CSB-BP370673MOP
CSB-MP370673MOP
CSB-EP370673MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans 50S ribosomal protein L13 (rplM) CSB-YP370674MOP
CSB-EP370674MOP
CSB-BP370674MOP
CSB-MP370674MOP
CSB-EP370674MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans Phosphoglucosamine mutase (glmM) CSB-YP370675MOP
CSB-EP370675MOP
CSB-BP370675MOP
CSB-MP370675MOP
CSB-EP370675MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans Alanine racemase (alr) CSB-YP370676MOP
CSB-EP370676MOP
CSB-BP370676MOP
CSB-MP370676MOP
CSB-EP370676MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans 60 kDa chaperonin 1 (groL1), partial CSB-YP370677MOP
CSB-EP370677MOP
CSB-BP370677MOP
CSB-MP370677MOP
CSB-EP370677MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans 1D-myo-inositol 2-acetamido-2-deoxy-alpha-D-glucopyranoside deacetylase (mshB) CSB-YP370678MOP
CSB-EP370678MOP
CSB-BP370678MOP
CSB-MP370678MOP
CSB-EP370678MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans tRNA (guanine-N (7)-)-methyltransferase CSB-YP370679MOP
CSB-EP370679MOP
CSB-BP370679MOP
CSB-MP370679MOP
CSB-EP370679MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans Succinate-semialdehyde dehydrogenase [NADP (+)] 1 CSB-YP370680MOP
CSB-EP370680MOP
CSB-BP370680MOP
CSB-MP370680MOP
CSB-EP370680MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans Glutamate-ammonia-ligase adenylyltransferase (glnE), partial CSB-YP370681MOP
CSB-EP370681MOP
CSB-BP370681MOP
CSB-MP370681MOP
CSB-EP370681MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans 60 kDa chaperonin 2 (groL2), partial CSB-YP370682MOP
CSB-EP370682MOP
CSB-BP370682MOP
CSB-MP370682MOP
CSB-EP370682MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans Bifunctional protein FolD (folD) CSB-YP370683MOP
CSB-EP370683MOP
CSB-BP370683MOP
CSB-MP370683MOP
CSB-EP370683MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium ulcerans Deoxyguanosinetriphosphate triphosphohydrolase-like protein (MUL_1458) CSB-YP370684MOP
CSB-EP370684MOP
CSB-BP370684MOP
CSB-MP370684MOP
CSB-EP370684MOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>